Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,025,594,398
-
Share change
-
-16,499,320
-
Total reported value
-
$82,642,729,287
-
Put/Call ratio
-
119%
-
Price per share
-
$80.59
-
Number of holders
-
2,023
-
Value change
-
-$1,357,273,013
-
Number of buys
-
876
-
Number of sells
-
1,018
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q1 2019
As of 31 Mar 2019,
AbbVie Inc. - Common Stock (ABBV) was held by
2,023 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,025,594,398 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Orbis Allan Gray Ltd, Capital World Investors, and Bank of New York Mellon Corp.
This page lists
2,024
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.